
Vitalhub Corp. (TSE:VHI – Free Report) – Equities researchers at Roth Capital lowered their FY2025 earnings per share estimates for Vitalhub in a research report issued on Monday, November 10th. Roth Capital analyst R. Baldry now forecasts that the company will earn $0.08 per share for the year, down from their prior estimate of $0.14. The consensus estimate for Vitalhub’s current full-year earnings is $0.23 per share. Roth Capital also issued estimates for Vitalhub’s Q4 2025 earnings at $0.04 EPS.
Several other equities research analysts have also commented on the stock. Stifel Canada raised shares of Vitalhub to a “strong-buy” rating in a research report on Tuesday, October 14th. TD Securities upped their target price on shares of Vitalhub from C$15.00 to C$16.00 and gave the company a “buy” rating in a report on Monday, August 11th. Royal Bank Of Canada set a C$15.00 price target on shares of Vitalhub and gave the stock a “moderate buy” rating in a research report on Thursday, September 18th. Stifel Nicolaus set a C$15.00 price objective on shares of Vitalhub and gave the company a “buy” rating in a research report on Wednesday, October 15th. Finally, Raymond James Financial raised their target price on Vitalhub from C$14.50 to C$15.00 and gave the stock an “outperform” rating in a report on Tuesday, August 12th. Two investment analysts have rated the stock with a Strong Buy rating and seven have issued a Buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of C$14.86.
Vitalhub Stock Performance
Shares of TSE:VHI opened at C$9.29 on Wednesday. The stock’s 50-day simple moving average is C$10.95 and its two-hundred day simple moving average is C$11.46. The stock has a market capitalization of C$583.69 million, a price-to-earnings ratio of 116.13, a PEG ratio of 1.18 and a beta of 0.70. Vitalhub has a 52-week low of C$8.50 and a 52-week high of C$14.64.
Insiders Place Their Bets
In other news, Director Steve Garrington sold 20,000 shares of the stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of C$12.90, for a total value of C$258,000.00. Following the completion of the sale, the director directly owned 60,000 shares of the company’s stock, valued at C$774,000. This represents a 25.00% decrease in their ownership of the stock. Also, Director Danny Matlow sold 150,000 shares of Vitalhub stock in a transaction on Thursday, August 28th. The shares were sold at an average price of C$12.75, for a total transaction of C$1,912,500.00. Following the transaction, the director owned 520,001 shares in the company, valued at approximately C$6,630,012.75. This trade represents a 22.39% decrease in their position. Corporate insiders own 18.57% of the company’s stock.
About Vitalhub
Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.
Recommended Stories
- Five stocks we like better than Vitalhub
- Canadian Penny Stocks: Can They Make You Rich?
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Strategy Shares Plunge as Bitcoin Retreats—More Pain Ahead?
- Investing In Automotive Stocks
- BigBear.ai Stock Is Range-Bound—Wall Street Isn’t Buying the Hype
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
